Insider Transactions
Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Jun 26, 2008 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | $1.41 | 216,216 |
Jun 25, 2008 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100 | $1.48 | 186,216 |
Mar 25, 2008 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 18,000 | -- | 184,434 |
Mar 25, 2008 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | $2.55 | 50,000 |
Dec 06, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | $3.15 | 50,000 |
Nov 21, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $2.72 | 166,434 |
Aug 01, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | $3.58 | 161,316 |
Jul 20, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 156,316 |
Jul 20, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 150,000 | $6.90 | 150,000 |
Jun 08, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 110,845 |
Jun 08, 2007 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 105,845 |
Dec 08, 2006 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 150,000 | -- | 150,000 |
Sep 26, 2006 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 100,000 |
Jun 14, 2006 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 2,500 | $3.75 | 78,034 |
Apr 03, 2006 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Exercise of in-the-money or at-the-money derivative security | 5,750 | $3.00 | 75,140 |
Apr 03, 2006 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Exercise of in-the-money or at-the-money derivative security | 5,750 | -- | -- |
Dec 06, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 69,390 |
Dec 06, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 100,000 |
Jun 29, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,000 | $4.20 | 39,390 |
May 19, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 200 | $4.70 | 36,990 |
May 19, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Open market or private purchase of non-derivative or derivative security | 1,400 | $4.72 | 38,390 |
Jan 03, 2005 |
Chief Scientific Officer
|
Chief Scientific Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 100,000 | -- | 100,000 |
Jan 03, 2011 |
CSO and Head of R&D Operations
|
CSO and Head of R&D Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 40,000 |
Jan 03, 2011 |
CSO and Head of R&D Operations
|
CSO and Head of R&D Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 50,000 |
Jul 23, 2010 |
CSO and Head of R&D Operations
|
CSO and Head of R&D Operations | Form 5 | Open market or private purchase of non-derivative or derivative security | 1,125 | $3.91 | 22,818 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.